SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001683168-22-007203
Filing Date
2022-11-02
Accepted
2022-11-02 11:13:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHDEULE 13G sunshine_sc13g.htm SC 13G 63298
  Complete submission text file 0001683168-22-007203.txt   64826
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Subject) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85054 | Film No.: 221352798
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 1730 RUE SAINT-PATRICK UNIT 601 MONTREAL Z4 H3K0B2
Business Address
Chamoun Malek (Filed by) CIK: 0001951769 (see all company filings)

Type: SC 13G